MR-guided prostate interventions

Journal of Magnetic Resonance Imaging

Volumn 27, Issue 2, 2008, Pages 356-367

  Tempany, Clare ^a   Straus, Sarah ^a   Hata, Nobuhiko ^a   Haker, Steven ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Image registration; Image segmentation; MR imaging; MR intervention; Prostate cancer

Indexed keywords

BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; TRANSRECTAL ULTRASONOGRAPHY;

BIOPSY; BRACHYTHERAPY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; PROSTATE; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 38949120488     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21259     Document Type: Review

References (81)

1. Gray MA, Delahunt B, Fowles JR, Weinstein P, Cookes RR, Nacey JN. Demographic and clinical factors as determinants of serum levels of prostate specific antigen and its derivatives. Anticancer Res 2004;24:2069-2072.
2. Powell IJ, Banerjee M, Novallo M, et al. Should the age specific prostate specific antigen cutoff for prostate biopsy be higher for black than for white men older than 50 years? J Urol 2000;163:146-148; discussion 148-149.
3. Efstathiou JA, Chen MH, Catalona WJ, et al. Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality. Urology 2006;68:342-347.
4. Cheng D, Tempany CM. MR imaging of the prostate and bladder. Semin Ultrasound CT MR 1998;19:67-89.
5. Ellis JH, Tempany C, Sarin MS, Gatsonis C, Rifkin MD, McNeil BJ. MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. AJR Am J Roentgenol 1994;162:865-872.
6. Tempany CM, Partin AW, Zerhouni EA, Zinreich SJ, Walsh PC. The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasia. Prostate 1993;22:39-42.
7. Tempany CM, Rahmouni AD, Epstein JI, Walsh PC, Zerhouni EA. Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imaging. Radiology 1991;181:107-112.
8. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003;348:2491-2499.
9. Harisinghani MG, Saini S, Weissleder R, et al. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentgenol 1999;172:1347-1351.
10. Schnall MD, Imai Y, Tomaszewski J, Pollack HM, Lenkinski RE, Kressel HY. Prostate cancer: local staging with endorectal surface coil MR imaging. Radiology 1991;178:797-802.
11. Schnall MD, Lenkinski RE, Pollack HM, Imai Y, Kressel HY. Prostate: MR imaging with an endorectal surface coil. Radiology 1989;172:570-574.
12. Way WG, Jr., Brown JJ, Lee JK, Gutierrez E, Andriole GL. MR imaging of benign prostatic hypertrophy using a Helmholtz-type surface coil. Magn Reson Imaging 1992;10:341-349.
13. Schnall MD, Bezzi M, Pollack HM, Kressel HY. Magnetic resonance imaging of the prostate. Magn Reson Q 1990;6:1-16.
14. Tempany CM, Zhou X, Zerhouni EA, et al. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology 1994;192:47-54.
15. Getty DJ, Seltzer SE, Tempany CM, Pickett RM, Swets JA, McNeil BJ. Prostate cancer: relative effects of demographic, clinical, histologic, and MR imaging variables on the accuracy of staging. Radiology 1997;204:471-479.
16. Seltzer SE, Getty DJ, Tempany CM, et al. Staging prostate cancer with MR imaging: a combined radiologist-computer system. Radiology 1997;202:219-226.
17. desouza NM, Reinsberg SA, Scurr ED, Brewster JM, Payne GS. Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol 2007;80:90-95.
18. Futterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006;241:449-458.
19. Gibbs P, Tozer DJ, Liney GP, Turnbull LW. Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med 2001;46:1054-1058.
20. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis - correlation with biopsy and histopathology. J Magn Reson Imaging 2006;24:108-113.
21. Mulkern RV, Barnes AS, Haker SJ, et al. Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. Magn Reson Imaging 2006;24:563-568.
22. Scheenen TW, Klomp DW, Roll SA, Futterer JJ, Barentsz JO, Heerschap A. Fast acquisition-weighted three-dimensional proton MR spectroscopic imaging of the human prostate. Magn Reson Med 2004;52:80-88.
23. Yu KK, Scheidler J, Hricak H, et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 1999;213:481-488.
24. Salomon L, Levrel O, Anastasiadis AG, et al. Outcome and complications of radical prostatectomy in patients with PSA <10 ng/ml: comparison between the retropubic, perineal and laparoscopic approach. Prostate Cancer Prostatic Dis 2002;5:285-290.
25. Bahn DK, Lee F. Cryosurgical ablation therapy for prostate cancer. Arch Ital Urol Androl 2000;72:302-304.
26. Weersink RA, Bogaards A, Gertner M, et al. Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities. J Photochem Photobiol 2005;79:211-222.
27. Schenck JF, Jolesz FA, Roemer PB, et al. Superconducting open-configuration MR imaging system for image-guided therapy. Radiology 1995;195:805-814.
28. D'Amico AV, Tempany CM, Schultz D, et al. Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate. Urology 2003;62;1063-1067.
29. D'Amico AV, Cormack R, Tempany CM, et al. Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1998;42:507-515.
30. Gering DT, Nabavi A, Kikinis R, et al. An integrated visualization system for surgical planning and guidance using image fusion and an open MR. J Magn Reson Imaging 2001;13:967-975.
31. Cormack RA, D'Amico AV, Kooy HM, Tempany CM; Brigham and Women's Hospital, assignee. Radiation seed implant method and apparatus. USA patent 6311084. October 30 2001.
32. Menard C, Susil RC, Choyke P, et al. MR guided HDR prostate brachytherapy in standard 1.5T scanner. Int J Radiat Oncol Biol Phys 2004;59:1414-1423.
33. Susil RC, Camphausen K, Choyke P, et al. System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner. Magn Reson Med 2004;52:683-687.
34. Albert M, Tempany CM, Schultz D, et al. Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer 2003;98:949-954.
35. Cormack RA, Kooy H, Tempany CM, D'Amico AV. A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2000;46:207-214.
36. D'Amico A, Cormack R, Kumar S, Tempany CM. Real-time magnetic resonance imaging-guided brachytherapy in the treatment of selected patients with clinically localized prostate cancer. J Endourol 2000;14:367-370.
37. D'Amico AV, Cormack RA, Tempany CM. MRI-guided diagnosis and treatment of prostate cancer. N Engl J Med 2001;344:776-777.
38. Das P, Chen MH, Valentine K, et al. Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce. Int J Radiat Oncol Biol Phys 2002;54:698-702.
39. Hurwitz MD, Cormack R, Tempany CM, Kumar S, D'Amico AV. Three-dimensional real-time magnetic resonance-guided interstitial prostate brachytherapy optimizes radiation dose distribution resulting in a favorable acute side effect profile in patients with clinically localized prostate cancer. Tech Urol 2000;6:89-94.
40. Cormack RA, D'Amico AV, Hata N, Silverman S, Weinstein M, Tempany CM. Feasibility of transperineal prostate biopsy under interventional magnetic resonance guidance. Urology 2000;56:663-664.
41. D'Amico AV, Tempany CM, Cormack R, et al. Transperineal magnetic resonance image guided prostate biopsy. J Urol 2000;164:385-387.
42. Hata N, Jinzaki M, Kacher D, et al. MR imaging-guided prostate biopsy with surgical navigation software: device validation and feasibility. Radiology 2001;220:263-268.
43. So MJ, Haker S, Zou KH, et al. Clinical evaluation of MR-guided prostate biopsy. In: Proc ISMRM, Miami; 2005. p 264.
44. Susil RC, Krieger A, Derbyshire JA, et al. System for MR image-guided prostate interventions: canine study. Radiology 2003;228:886-894.
45. Krieger A, Susil RC, Menard C, et al. Design of a novel MRI compatible manipulator for image guided prostate interventions. IEEE Trans Biomed Eng 2005;52:306-313.
46. Susil RC, Menard C, Krieger A, et al. Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner. J Urol 2006;175:113-120.
47. Beyersdorff D, Winkel A, Hamm B, Lenk S, Loening SA, Taupitz M. MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology 2005;234:576-581.
48. Engelhard K, Hollenbach HP, Kiefer B, Winkel A, Goeb K, Engehausen D. Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device. Eur Radiol 2006;16:1237-1243.
49. Zangos S, Herzog C, Eichler K, et al. MR-compatible assistance system for punction in a high-field system: device and feasibility of transgluteal biopsies of the prostate gland. Eur Radiol 2007;17:1118-1124.
50. Hirose M, Bharatha A, Hata N, et al. Quantitative MR imaging assessment of prostate gland deformation before and during MR imaging-guided brachytherapy. Acad Radiol 2002;9:906-912.
51. Kim Y, Hsu IC, Pouliot J, Noworolski SM, Vigneron DB, Kurhanewicz J. Expandable and rigid endorectal coils for prostate MRI: impact on prostate distortion and rigid image registration. Med Phys 2005;32:3569-3578.
52. Steenbakkers RJ, Duppen JC, Betgen A, et al. Impact of knee support and shape of tabletop on rectum and prostate position. Int J Radiat Oncol Biol Phys 2004;60:1364-1372.
53. Nichol AM, Brock KK, Lockwood GA, et al. A magnetic resonance imaging study of prostate deformation relative to implanted gold fiducial markers. Int J Radiat Oncol Biol Phys 2007;67:48-56.
54. Bharatha A, Hirose M, Hata N, et al. Evaluation of three-dimensional finite element-based deformable registration of pre- and intraoperative prostate imaging. Med Phys 2001;28:2551-2560.
55. Alterovitz R, Goldberg K, Pouliot J, et al. Registration of MR prostate images with biomechanical modeling and nonlinear parameter estimation. Med Phys 2006;33:446-454.
56. Fei B, Duerk JL, Sodee DB, Wilson DL. Semiautomatic nonrigid registration for the prostate and pelvic MR volumes. Acad Radiol 2005;12:815-824.
57. Fei B, Kemper C, Wilson DL. A comparative study of warping and rigid body registration for the prostate and pelvic MR volumes. Comput Med Imaging Graph 2003;27:267-281.
58. Venugopal N, McCurdy B, Hnatov A, Dubey A. A feasibility study to investigate the use of thin-plate splines to account for prostate deformation. Phys Med Biol 2005;50:2871-2885.
59. Fei B, Duerk JL, Wilson DL. Automatic 3D registration for interventional MRI-guided treatment of prostate cancer. Comput Aided Surg 2002;7:257-267.
60. Fei B, Wheaton A, Lee Z, Duerk JL, Wilson DL. Automatic MR volume registration and its evaluation for the pelvis and prostate. Phys Med Biol 2002;47:823-838.
61. Wu X, Dibiase SJ, Gullapalli R, Yu CX. Deformable image registration for the use of magnetic resonance spectroscopy in prostate treatment planning. Int J Radiat Oncol Biol Phys 2004;58:1577-1583.
62. Lee Z, Nagano KK, Duerk JL, Sodee DB, Wilson DL. Automatic registration of MR and SPECT images for treatment planning in prostate cancer. Acad Radiol 2003;10:673-684.
63. Pasquier D, Lacornerie T, Vermandel M, Rousseau J, Lartigau E, Betrouni N. Automatic segmentation of pelvic structures from magnetic resonance images for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2007;68:592-600.
64. Tsai A, Wells W, Tempany C, Grimson E, Willsky A. Coupled multi-shape model and mutual information for medical image segmentation. Inf Process Med Imaging 2003;18:185-197.
65. Barnes AS, Haker SJ, Mulkern RV, So M, D'Amico AV, Tempany CM. Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer. Urology 2005;66:1319.
66. Chan I, Wells W 3rd, Mulkern RV, et al. Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging: a multichannel statistical classifier. Med Phys 2003;30:2390-2398.
67. Selli C, Caramella D, Giusti S, et al. Value of image fusion in the staging of prostatic carcinoma. Radiol Med (Torino) 2007;112:74-81.
68. Lee JS, Chung BH. Transrectal ultrasound versus magnetic resonance imaging in the estimation of prostate volume as compared with radical prostatectomy specimens. Urol Int 2007;78:323-327.
69. Rahmouni A, Yang A, Tempany CM, et al. Accuracy of in-vivo assessment of prostatic volume by MRI and transrectal ultrasonography. J Comput Assist Tomogr 1992;16:935-940.
70. Smith WL, Lewis C, Bauman G, et al. Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR. Int J Radiat Oncol Biol Phys 2007;67:1238-1247.
71. Schreibmann E, Xing L. Narrow band deformable registration of prostate magnetic resonance imaging, magnetic resonance spectroscopic imaging, and computed tomography studies. Int J Radiat Oncol Biol Phys 2005;62:595-605.
72. Mizowaki T, Cohen GN, Fung AY, Zaider M. Towards integrating functional imaging in the treatment of prostate cancer with radiation: the registration of the MR spectroscopy imaging to ultrasound/CT images and its implementation in treatment planning. Int J Radiat Oncol Biol Phys 2002;54:1558-1564.
73. Lattouf JB, Grubb RL 3rd, Lee SJ, et al. Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer. BJU Int 2007;99:1041-1046.
74. Daanen V, Gastaldo J, Giraud JY, et al. MRI/TRUS data fusion for brachytherapy. Int J Med Robot 2006;2:256-261.
75. Reynier C, Troccaz J, Fourneret P, et al. MRI/TRUS data fusion for prostate brachytherapy. Preliminary results. Med Phys 2004;31:1568-1575.
76. Gelet A, Chapelon JY, Bouvier R, Pangaud C, Lasne Y. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results. J Urol 1999;161:156-162.
77. Gelet A, Chapelon JY, Bouvier R, Rouviere O, Lyonnet D, Dubernard JM. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol 2001;40:124-129.
78. McDannold N, King RL, Jolesz FA, Hynynen K. The use of quantitative temperature images to predict the optimal power for focused ultrasound surgery: in vivo verification in rabbit muscle and brain. Med Phys 2002;29:356-365.
79. Hynynen K, Pomeroy O, Smith DN, et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 2001;219:176-185.
80. Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 2003;226:897-905.
81. Fischer GS, DiMaio SP, Iordachita I, Fichtinger G. Development of a robotic assistant for needle-based transperineal prostate interventions in MRI. In: Proc 10th Int'l Conference on Medical Image Computing and Computer-Assisted Intervention, MICCAI 2007, LNCS 4791, Nov. 2007. pp 425-433.